Global Hereditary Angioedema Market Forecast 2018-2028 - Visiongain Report

LONDON, June 8, 2018 /PRNewswire/ --

C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor (Kalbitor), Cinryze, Berinert, Ruconest, Intravenous, Subcutaneous Injection, Oral, Hospital Pharmacies, Retail Pharmacies

The global hereditary angioedema market is expected to grow at a CAGR of 8.8% in the first half of the forecast period. In 2017, the C1 Esterase Inhibitor segment held 42% of this market.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 232-page report you will receive 82 tables and 130 figures- all unavailable elsewhere.

The 232-page report provides clear detailed insight into the global hereditary angioedema market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Hereditary Angioedema Market Forecast from 2018-2028

• This report also breaks down the revenue forecast for the global hereditary angioedema market by drug class:
• C1 Esterase Inhibitor: Cinryze, Berinert, Ruconest
• Selective Bradykinin B2 Receptor Antagonist
• Kallikrein Inhibitor (Kalbitor)

This report also provides a market attractiveness index by drug class.

• This report also breaks down the revenue forecast for the global hereditary angioedema market by route of administration:
• Intravenous
• Subcutaneous Injection
• Oral

This report also provides a market attractiveness index by route of administration.

• This report also breaks down the revenue forecast for the global hereditary angioedema market by distribution channel:
• Hospital Pharmacies
• Retail Pharmacies

This report also provides a market attractiveness index by distribution channel

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: The U.S., Canada
• Latin America: Brazil, Mexico, Rest of Latin America
• Europe: U.K., Germany, Spain, France, Italy, Russia, Rest of Europe
• Asia-Pacific: China, India, Japan, Australia and New Zealand, South Korea, ASEAN, Rest of Asia-Pacific
• Middle East: GCC Countries, Israel, Rest of Middle East
• Africa: South Africa, Central Africa, North Africa

This report also provides a market attractiveness index by region

The forecast for each regional market is further broken down by drug class, product, route of administration and distribution channel

This report provides a market attractiveness index by drug class, product, route of administration and distribution channel for each regional market

• Our study discusses the selected leading companies that are the major players in the global hereditary angioedema industry:
• BioCryst Pharmaceuticals, Inc.
• CSL Limited
• iBio, Inc.
• Ionis Pharmaceuticals, Inc.
• Pharming Group NV
• Santarus, Inc.
• Shire PLC

• This report discusses factors that drive and restrain the market, as well as trends and opportunities.

Visiongain's study is intended for anyone requiring commercial analyses for the global hereditary angioedema market. You find data, trends and predictions.

Buy our report today Global Hereditary Angioedema Market Forecast 2018-2028: C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor (Kalbitor), Cinryze. Berinert, Ruconest, Intravenous, Subcutaneous Injection, Oral, Hospital Pharmacies, Retail Pharmacies.

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website : https://www.visiongain.com/Report/2203/Global-Hereditary-Angioedema-Market-Forecast-2018-2028

Companies Listed 

AmeriCare
BioCryst Pharmaceuticals, Inc
Clinigen Group plc
CSL Behring
CSL Intellectual Property
CSL Limited
Dyax Corp.
Fiocruz
HAEi International Patient Organization
iBio, Inc.
iBio, Inc.
Idera Pharmaceuticals
Inceptua Medicines Access
Ionis Pharmaceuticals, Inc.
Pharming Group NV
Prime Therapeutics LLC
Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Ltd.
Sanquin Blood Supply
Santarus, Inc.
Seqirus
Shire plc
United States of America US Hereditary Angioedema Association
Valeant Pharmaceuticals International, Inc.
ViroPharma Inc.
World Allergy Organization

To see a report overview please e-mail Sara Peerun on [email protected]

SOURCE Visiongain